Teleflex (NYSE:TFX) Shares Gap Down – Here’s What Happened

Teleflex Incorporated (NYSE:TFX)’s share price gapped down before the market opened on Thursday . The stock had previously closed at $126.53, but opened at $112.50. Teleflex shares last traded at $113.3870, with a volume of 720,314 shares.

Analyst Ratings Changes

A number of analysts recently commented on the company. Zacks Research cut Teleflex from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 30th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research note on Monday, December 29th. Wall Street Zen downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Wells Fargo & Company boosted their price objective on shares of Teleflex from $114.00 to $139.00 and gave the company an “equal weight” rating in a research report on Wednesday, December 10th. Finally, Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Tuesday, December 9th. One analyst has rated the stock with a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Reduce” and a consensus price target of $142.43.

Teleflex Stock Down 13.0%

The firm has a fifty day simple moving average of $118.78 and a 200 day simple moving average of $121.23. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57. The company has a market cap of $4.86 billion, a PE ratio of -15.04, a PEG ratio of 1.39 and a beta of 0.93.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 earnings per share for the quarter, topping the consensus estimate of $3.38 by $0.29. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The business had revenue of $892.90 million for the quarter, compared to analyst estimates of $892.79 million. During the same period in the prior year, the firm posted $3.49 EPS. The company’s revenue was up 19.4% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. Equities research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, December 15th. Shareholders of record on Friday, November 14th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date was Friday, November 14th. Teleflex’s dividend payout ratio (DPR) is -18.50%.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. United Services Automobile Association acquired a new stake in Teleflex during the first quarter worth about $373,000. Empowered Funds LLC lifted its stake in shares of Teleflex by 15.8% in the 1st quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock valued at $233,000 after purchasing an additional 230 shares in the last quarter. Jane Street Group LLC grew its holdings in shares of Teleflex by 42.6% during the 1st quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock worth $877,000 after purchasing an additional 1,895 shares during the period. IFM Investors Pty Ltd increased its position in Teleflex by 7.8% during the 1st quarter. IFM Investors Pty Ltd now owns 8,311 shares of the medical technology company’s stock worth $1,148,000 after purchasing an additional 602 shares in the last quarter. Finally, Strs Ohio acquired a new stake in Teleflex during the 1st quarter worth approximately $3,040,000. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.